Clinical
RSSArticles
-
Antisocial Behavioral Syndromes in the United States
Whether treatment for the numerous other comorbidities, such as substance abuse associated with antisocial personality disorder, will hasten time to remission is an area of needed research.
-
Preventing Sickle Cell Disease Pain Crises
Crizanlizumab has been demonstrated to be highly effective in reducing painful crises related to sickle cell disease.
-
Recognizing Binge Eating Disorder
Because binge eating disorder is more common in persons with obesity, screening potentially is more useful in this population.
-
FDA Action
The FDA has approved brodalumab to treat adults with moderate-to-severe plaque psoriasis.
-
A Possible New Hope for Leukemia Patients
Treatment with blinatumomab resulted in significantly longer overall survival than chemotherapy among adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
-
Comparing Treatments for Atopic Dermatitis
A new interleukin-31 inhibitor is under evaluation for the treatment of atopic dermatitis.
-
Breakthrough in Rheumatoid Arthritis Treatment?
In a recent trial, baricitinib was associated with significant clinical improvements as compared with placebo and adalimumab.
-
Popular Drug Could Help Prevent Type 2 Diabetes
Does liraglutide play a role in the prevention of type 2 diabetes?
-
Antithrombotic Drug Use Associated with Higher Risk of Subdural Hematoma
This study suggests that the newer direct oral anticoagulants may be safer in this regard than warfarin therapy.
-
Months After SPRINT, Clinicians Continue Debating Appropriate Blood Pressure Targets
Concerns linger that aggressive BP management might affect mobility in those > 75 years of age.